نتائج البحث

Naltrexone in AUD Reward Drinkers

• Authors : Alkermes, Inc.

• Source: Testing the Reward-Drinker Hypothesis of Naltrexone Using an Extended-Release Formulation

تفاصيل العنوان

Harm Reduction With Pharmacotherapy (HaRP) (HaRP)

• Authors : National Institute on Alcohol Abuse and Alcoholism (NIAAA); Alkermes, Inc.; Susan Collins, Professor

• Source: Harm Reduction With Pharmacotherapy for Homeless Adults With Alcohol DependenceCollins SE, Saxon AJ, Duncan MH, Smart BF, Merrill JO, Malone DK, Jackson TR, Clifasefi SL, Joesch J, Ries RK. Harm

تفاصيل العنوان

VIVITROL as a Treatment for Cocaine and Alcohol Dependence

• Authors : Alkermes, Inc.; National Institute on Drug Abuse (NIDA); Kyle Kampman, Principal Investigator

• Source: A Phase II, Randomized, Double-Blind Pilot Trial of VIVITROL® (Naltrexone for Extended-Release Injectable Suspension) for the Treatment of Cocaine and Alcohol Dependence

تفاصيل العنوان

Extended-release Naltrexone for Alcohol Dependence in Primary Care

• Authors : Alkermes, Inc.; Marc Gourevitch, Director of General Internal Medicine

• Source: Extended-release Naltrexone (Vivitrol) for the Treatment of Alcohol Dependence in Urban Primary Care: a Feasibility StudyLee JD, Grossman E, DiRocco D, Truncali A, Hanley K, Stevens D, Rotrosen

تفاصيل العنوان

BUSINESS.

• Source: Alcoholism & Drug Abuse Weekly. 6/23/2008, Vol. 20 Issue 25, p8-8. 1/9p.

تفاصيل العنوان

Effects of the Opioid System Modulator, Samidorphan, on Measures of Alcohol Consumption and Patient-Reported Outcomes in Adults with Alcohol Dependence.

• Authors : O'Malley SS; Department of Psychiatry, Yale School of Medicine, New Haven, Connecticut.; Todtenkopf MS

Subjects: Patient Reported Outcome Measures*; Alcoholism/Alcoholism/Alcoholism/*drug therapy ; Naltrexone/Naltrexone/Naltrexone/*analogs & derivatives

• Source: Alcoholism, clinical and experimental research [Alcohol Clin Exp Res] 2018 Oct; Vol. 42 (10), pp. 2011-2021. Date of Electronic Publication: 2018 AugPublisher: Wiley-Blackwell Country of Publication: England NLM ID: 7707242 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

Treatment Journey and Healthcare Resource Use Among Patients With Alcohol Use Disorder Who Initiated Extended-Release Naltrexone: An Analysis of Veterans Affairs Data.

• Authors : Grebla, Regina¹ (AUTHOR) ; Liu, Jieruo¹ (AUTHOR); O'Sullivan, Amy K¹ (AUTHOR)

• Source: Substance Use: Research & Treatment. 9/26/2024, p1-11. 11p.

تفاصيل العنوان

A Study of ALKS 3831 in Subjects With Schizophrenia and Alcohol Use Disorder

• Source: A Phase 2, Efficacy, Safety and Tolerability Study of ALKS 3831 in Schizophrenia With Alcohol Use DisorderBrunette MF, Correll CU, O'Malley SS, McDonnell D, DiPetrillo L, Jiang Y, Simmons A,

تفاصيل العنوان

ALK21-003: Study of Medisorb® Naltrexone (VIVITROL®) in Alcohol-Dependent Adults

• Authors : Bernard Silverman, MD, Vice President, Clinical Development

• Source: A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Medisorb® Naltrexone in Alcohol-Dependent AdultsGarbutt JC, Kranzler HR, O'Malley SS,

تفاصيل العنوان

ALK21-010: Long-term Safety of Medisorb® Naltrexone (VIVITROL®) in Alcohol-dependent Adults

• Authors : Bernard L. Silverman, MD / VP, Clinical Development

• Source: A Multi-Center Extension of Alkermes' Study ALK21-003-EXT (NCT01218971) to Evaluate the Long-Term Safety of Medisorb® NaltrexoneO'Brien CP, Gastfriend DR, Forman

تفاصيل العنوان